Cargando…

PG F(2α) Receptor: A Promising Therapeutic Target for Cardiovascular Disease

Prostaglandins (PGs), a group of key lipid mediators, are involved in numerous physiological and pathological processes including inflammation and cardiovascular homeostasis. Each PG acts on its specific and distinct cell surface G protein-coupled receptors (GPCRs) or peroxisome proliferator-activat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jian, Gong, Yanjun, Yu, Ying
Formato:	Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2010
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095374/ https://www.ncbi.nlm.nih.gov/pubmed/21607067 http://dx.doi.org/10.3389/fphar.2010.00116

Ejemplares similares

The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
por: Dalefield, Martin L., et al.
Publicado: (2022)

Receptor Interacting Protein Kinases 1/3: The Potential Therapeutic Target for Cardiovascular Inflammatory Diseases
por: Leng, Yiming, et al.
Publicado: (2021)

I(f) Channel as an Emerging Therapeutic Target for Cardiovascular Diseases: A Review of Current Evidence and Controversies
por: Mengesha, Hayelom G., et al.
Publicado: (2017)

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
por: Xiao, Cuicui, et al.
Publicado: (2020)

Epac: A Promising Therapeutic Target for Vascular Diseases: A Review
por: Pan, Yunfeng, et al.
Publicado: (2022)

From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
por: Zhu, Yumeng, et al.
Publicado: (2022)

Promising Antioxidative Effect of Berberine in Cardiovascular Diseases
por: An, Na, et al.
Publicado: (2022)

TRPV1: A promising therapeutic target for skin aging and inflammatory skin diseases
por: Xiao, Tengfei, et al.
Publicado: (2023)

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
por: Sun, Huiyan, et al.
Publicado: (2023)

Natural compounds targeting glycolysis as promising therapeutics for gastric cancer: A review
por: Zhao, Maoyuan, et al.
Publicado: (2022)

Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
por: Xu, Jingqi, et al.
Publicado: (2021)

FUN14 Domain Containing 1 (FUNDC1): A Promising Mitophagy Receptor Regulating Mitochondrial Homeostasis in Cardiovascular Diseases
por: Mao, Yu, et al.
Publicado: (2022)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
por: Li, Chao, et al.
Publicado: (2020)

G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases
por: Murga, Cristina, et al.
Publicado: (2019)

CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
por: Battastini, Ana Maria Oliveira, et al.
Publicado: (2021)

Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment
por: Zhu, Guidong, et al.
Publicado: (2021)

Purinergic Receptors on Oligodendrocyte Progenitors: Promising Targets for Myelin Repair in Multiple Sclerosis?
por: Lecca, Davide, et al.
Publicado: (2021)

Adenosine A(3) Receptor: A Promising Therapeutic Target in Cardiovascular Disease
por: Nishat, Shamama, et al.
Publicado: (2016)

Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2018)

PPARα: A potential therapeutic target of cholestasis
por: Ye, Xiaoyin, et al.
Publicado: (2022)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
por: Zhou, Mengjiao, et al.
Publicado: (2022)

PRDM16 Regulating Adipocyte Transformation and Thermogenesis: A Promising Therapeutic Target for Obesity and Diabetes
por: Jiang, Na, et al.
Publicado: (2022)

RIPK2: a promising target for cancer treatment
por: You, Jieqiong, et al.
Publicado: (2023)

Nanocurcumin: A Promising Candidate for Therapeutic Applications
por: Karthikeyan, Adhimoolam, et al.
Publicado: (2020)

Plant-Derived Compounds as Promising Therapeutics for Vitiligo
por: Pang, Yaobin, et al.
Publicado: (2021)

Ferroptosis as a promising therapeutic strategy for melanoma
por: Ta, Na, et al.
Publicado: (2023)

G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease
por: Divorty, Nina, et al.
Publicado: (2015)

miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson’s disease
por: Suvarna, Vasanti, et al.
Publicado: (2022)

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
por: Cai, Yun, et al.
Publicado: (2021)

The TRPA1 Channel in the Cardiovascular System: Promising Features and Challenges
por: Wang, Zhen, et al.
Publicado: (2019)

Targeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disorders
por: Olney, Jeffrey J., et al.
Publicado: (2014)

Emodin in cardiovascular disease: The role and therapeutic potential
por: Guo, Yuanyuan, et al.
Publicado: (2022)

Oligonucleotides—A Novel Promising Therapeutic Option for IBD
por: Scarozza, Patrizio, et al.
Publicado: (2019)

Promising Role of Emodin as Therapeutics to Against Viral Infections
por: Shao, Qingqing, et al.
Publicado: (2022)

Targets of Vitamin C With Therapeutic Potential for Cardiovascular Disease and Underlying Mechanisms: A Study of Network Pharmacology
por: Zhu, Ning, et al.
Publicado: (2021)

Therapeutic targets by traditional Chinese medicine for ischemia-reperfusion injury induced apoptosis on cardiovascular and cerebrovascular diseases
por: Cheng, Xiuli, et al.
Publicado: (2022)

Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases
por: Yang, Yang, et al.
Publicado: (2023)

Vascular Adhesion Protein-1 (VAP-1)/Semicarbazide-Sensitive Amine Oxidase (SSAO): A Potential Therapeutic Target for Atherosclerotic Cardiovascular Diseases
por: Li, Hui, et al.
Publicado: (2021)

Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
por: Sheng, Lili, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qm9eotbam79cjos630b4jr7lnd